PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
8781526-2	1996	At equipotent doses (with respect to receptor blockade and behavioural tests), the dopamine D2-receptor selective sulpiride and remoxipride gave a conspicuous down-regulation of CYP2C11 and its associated androstenedione 16 alpha-hydroxylation activity as well as of the CYP2C11-specific mRNA.	Sulpiride	114-123	cytochrome P450, subfamily 2, polypeptide 11	Rattus norvegicus	178-185	
8781526-2	1996	At equipotent doses (with respect to receptor blockade and behavioural tests), the dopamine D2-receptor selective sulpiride and remoxipride gave a conspicuous down-regulation of CYP2C11 and its associated androstenedione 16 alpha-hydroxylation activity as well as of the CYP2C11-specific mRNA.	Sulpiride	114-123	cytochrome P450, subfamily 2, polypeptide 11	Rattus norvegicus	271-278	
8781526-2	1996	At equipotent doses (with respect to receptor blockade and behavioural tests), the dopamine D2-receptor selective sulpiride and remoxipride gave a conspicuous down-regulation of CYP2C11 and its associated androstenedione 16 alpha-hydroxylation activity as well as of the CYP2C11-specific mRNA.	Remoxipride	128-139	cytochrome P450, subfamily 2, polypeptide 11	Rattus norvegicus	178-185	
8781526-2	1996	At equipotent doses (with respect to receptor blockade and behavioural tests), the dopamine D2-receptor selective sulpiride and remoxipride gave a conspicuous down-regulation of CYP2C11 and its associated androstenedione 16 alpha-hydroxylation activity as well as of the CYP2C11-specific mRNA.	Remoxipride	128-139	cytochrome P450, subfamily 2, polypeptide 11	Rattus norvegicus	271-278	
8781526-2	1996	At equipotent doses (with respect to receptor blockade and behavioural tests), the dopamine D2-receptor selective sulpiride and remoxipride gave a conspicuous down-regulation of CYP2C11 and its associated androstenedione 16 alpha-hydroxylation activity as well as of the CYP2C11-specific mRNA.	Androstenedione	205-220	cytochrome P450, subfamily 2, polypeptide 11	Rattus norvegicus	178-185	
8781526-7	1996	In contrast, diverging effects were observed for clozapine, compared to sulpiride and remoxipride, on the immunoidentified CYP1A2, CYP2B1, and CYP3A.	Clozapine	49-58	cytochrome P450, family 1, subfamily a, polypeptide 2	Rattus norvegicus	123-129	
8781526-7	1996	In contrast, diverging effects were observed for clozapine, compared to sulpiride and remoxipride, on the immunoidentified CYP1A2, CYP2B1, and CYP3A.	Clozapine	49-58	cytochrome P450, family 2, subfamily b, polypeptide 1	Rattus norvegicus	131-137	
8781526-7	1996	In contrast, diverging effects were observed for clozapine, compared to sulpiride and remoxipride, on the immunoidentified CYP1A2, CYP2B1, and CYP3A.	Clozapine	49-58	cytochrome P450, family 3, subfamily a, polypeptide 62	Rattus norvegicus	143-148	
8781526-7	1996	In contrast, diverging effects were observed for clozapine, compared to sulpiride and remoxipride, on the immunoidentified CYP1A2, CYP2B1, and CYP3A.	Sulpiride	72-81	cytochrome P450, family 1, subfamily a, polypeptide 2	Rattus norvegicus	123-129	
8781526-7	1996	In contrast, diverging effects were observed for clozapine, compared to sulpiride and remoxipride, on the immunoidentified CYP1A2, CYP2B1, and CYP3A.	Sulpiride	72-81	cytochrome P450, family 2, subfamily b, polypeptide 1	Rattus norvegicus	131-137	
8781526-7	1996	In contrast, diverging effects were observed for clozapine, compared to sulpiride and remoxipride, on the immunoidentified CYP1A2, CYP2B1, and CYP3A.	Sulpiride	72-81	cytochrome P450, family 3, subfamily a, polypeptide 62	Rattus norvegicus	143-148	
8781526-7	1996	In contrast, diverging effects were observed for clozapine, compared to sulpiride and remoxipride, on the immunoidentified CYP1A2, CYP2B1, and CYP3A.	Remoxipride	86-97	cytochrome P450, family 1, subfamily a, polypeptide 2	Rattus norvegicus	123-129	
8781526-7	1996	In contrast, diverging effects were observed for clozapine, compared to sulpiride and remoxipride, on the immunoidentified CYP1A2, CYP2B1, and CYP3A.	Remoxipride	86-97	cytochrome P450, family 2, subfamily b, polypeptide 1	Rattus norvegicus	131-137	
8781526-7	1996	In contrast, diverging effects were observed for clozapine, compared to sulpiride and remoxipride, on the immunoidentified CYP1A2, CYP2B1, and CYP3A.	Remoxipride	86-97	cytochrome P450, family 3, subfamily a, polypeptide 62	Rattus norvegicus	143-148